MYOMO INC MYO
ASignal's systematic analysis rates MYO as Bearish.
Reflects the latest available analysis · analyzed Oct 31, 2026
The case on MYO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- High revenue growth (21.3% YoY)
- Strong gross margin (68.35%) indicating pricing power
- Current ratio of 2.31x suggests short-term liquidity strength
- Market valuation (EV/Revenue 1.29x) appears reasonable for a growth-stage healthcare device company
- Negative MACD and declining momentum (MACD histogram negative)
- Price below both SMA20 and SMA50, indicating downtrend
- Negative free cash flow (-$2.41M) and negative operating cash flow (-$7.11M)
- High debt-to-equity ratio (3.44x) signaling financial risk
- Negative return on equity (-123.76%) and negative profit margins (-33.53%)
- Forward P/E of -5.64x and negative EV/EBITDA suggest unprofitability
See the full verdict on MYO
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MYO
Most investors never get a second opinion, let alone several. ASignal runs MYO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.